id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340436-qiyoamek	Varshney, Anubodh S.	Characteristics of Clinical Trials Evaluating Cardiovascular Therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: A Cross Sectional Analysis	2020-10-26		.txt	text/plain	2675	147	39	title: Characteristics of Clinical Trials Evaluating Cardiovascular Therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: A Cross Sectional Analysis At present, a limited number of therapies have been shown to improve clinical outcomes in patients infected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) via randomized controlled trial (RCT) data 2,3 . We therefore evaluated registered clinical trials of established CV therapies related to COVID-19 using the ClinicalTrials.gov database, which was established to improve monitoring and conduct of research studies 14 . ClinicalTrials.gov has the following notable findings: 1) a minority of interventional studies related to COVID-19 registered on ClinicalTrials.gov plan to evaluate CV therapies or CV specific outcomes; 2) most studies are planned to be single center, enroll less than 1000 inpatients, sponsored by European or North American academic institutions; and 3) are estimated to complete after December 2020.	./cache/cord-340436-qiyoamek.txt	./txt/cord-340436-qiyoamek.txt